Algorithmic Biologics is a biotechnology research company based in Bangalore, Karnataka. Their vision is to create a bountiful and healthy world by bringing scale efficiencies to molecular discovery and diagnostics. They have a transdisciplinary team with a deep modeling-based understanding of the chemistry and mechanics of molecular technologies. Their first product, Tapestry, is an award-winning, regulatory approved algorithmic solution to provide affordable large-scale COVID-19 testing.

Manoj Gopalkrishnan

Algorithmic Biologics

Illumina provides sequencing and array solutions to advance genomic research. Their products include instruments, kits, reagents, software, and analysis services.

Metric
Company Name	Algorithmic Biologics	Illumina
Symbol
MSH ID	COM:ALGORITHMICBIOLOGICS	COM:ILLUMINA
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services
Industry	Biotechnology Research	Biotechnology
Country		US
Stage
Employee Count	1	9.14K
Website	algorithmicbiologics.com	illumina.com
LinkedIn
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic		937.78K
Web Traffic Growth		-0.07
Valuation
Raised Capital		500M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

ALGO

COM:ALGORITHMICBIOLOGICS

Algorithmic Biologics

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue